Literature DB >> 7781763

Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells.

I N Singh1, D G McCartney, J N Kanfer.   

Abstract

[3H]Myristic acid prelabeled LA-N-2 cells were exposed to varying concentrations of amyloid beta protein (25-35), from 20 to 250 micrograms/ml, and the activation of phospholipases A and D estimated. A progressive increase in phosphatidylethanol formation, a measure of phospholipase D activity, and of free fatty acid release, a measure of phospholipase A activity, was observed over a time-course of 60 min. [3H]Inositol prelabeled LA-N-2 cells were exposed to varying concentrations of A beta P, from 20 to 125 micrograms/ml, and phospholipase C activation was measured. There was an increased release of inositol phosphates in the presence of amyloid beta protein as a function of incubation time. The effects of adrenergic, metabotropic amino acid and bombesin antagonists on the A beta P mediated stimulation of phospholipase C activity was investigated. Propranolol, a beta adrenergic antagonist, 7-chloro-kynurenic acid, a metabotropic amino acid antagonist, and [Tyr4-D-Phe12]bombesin, a bombesin antagonist, blunted the A beta P stimulation of phospholipase C activity in [3H]inositol prelabeled LA-N-2 cells. This suggests that amyloid beta protein activation of phospholipase C may be receptor mediated. The phospholipase C inhibitor U 71322 prevented the activation of phospholipase C by A beta P. However, this activation was not effected by tocopherol, propylgallate, or vitamin C.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781763     DOI: 10.1016/0014-5793(95)00432-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

Review 2.  Phospholipase D in brain function and Alzheimer's disease.

Authors:  Tiago Gil Oliveira; Gilbert Di Paolo
Journal:  Biochim Biophys Acta       Date:  2010-04-23

3.  Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex.

Authors:  A Zambrzycka; R P Strosznajder; J B Strosznajder
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

4.  Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.

Authors:  Tiago Gil Oliveira; Robin B Chan; Huasong Tian; Mikael Laredo; Guanghou Shui; Agnieszka Staniszewski; Hong Zhang; Lili Wang; Tae-Wan Kim; Karen E Duff; Markus R Wenk; Ottavio Arancio; Gilbert Di Paolo
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

5.  Amyloid beta peptide 25-35 modulates hydrolysis of phosphoinositides by membrane phospholipase(s) C of adult brain cortex.

Authors:  J B Strosznajder; A Zambrzycka; M D Kacprzak; R P Strosznajder
Journal:  J Mol Neurosci       Date:  1999-04       Impact factor: 3.444

6.  Changes of enzyme activity in lipid signaling pathways related to substrate reordering.

Authors:  Dino G Salinas; Milton De La Fuente; Juan G Reyes
Journal:  Biophys J       Date:  2005-05-13       Impact factor: 4.033

7.  Activation of LA-N-2 cell phospholipase D by amyloid beta protein (25-35).

Authors:  I N Singh; G Sorrentino; J N Kanfer
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

8.  Activation of phospholipases A2 and D of a human neuroblastoma cell line (LA-N-2) by N-dodecyl-L-lysine amide (compound 24), a putative G protein activator: characteristics of inhibition by (-)-nicotine.

Authors:  Byron M Garnham; Shirley Fitzpatrick-Wong; Walter Schunack; Bernd Nürnberg; Giuseppe Sorrentino; Fiona E Parkinson; Julian N Kanfer; Daniel S Sitar
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

9.  PLD3 is accumulated on neuritic plaques in Alzheimer's disease brains.

Authors:  Jun-Ichi Satoh; Yoshihiro Kino; Yoji Yamamoto; Natsuki Kawana; Tsuyoshi Ishida; Yuko Saito; Kunimasa Arima
Journal:  Alzheimers Res Ther       Date:  2014-11-02       Impact factor: 6.982

Review 10.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.